Invizyne Technologies Inc (IZTC) Forward Price-to-Revenue Multiple
Stable supplies of bio-reagents minimize risks within synthesis chains, which is supported by the forward P/S multiple. The value of 0.00 represents the current level of this metric. This trend is driven by cell-free production methods for low-cost molecules and biofuels, as well as the development of advanced ecological synthesis systems that are radically transforming the modern industrial chemistry niche for Invizyne Technologies Inc. (IZTC).
IZTC (Invizyne Corp): analytical breakdowns and indicator data
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Capital Invizyne Technologies Inc.|IZTC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Invizyne Technologies Inc.|IZTC - Aggregate Debt Obligations|Debt to Book Value Invizyne Corp|IZTC - Amount of Long-Term Liabilities|Company Short-Term Debts Invizyne Technologies|Quick Ratio invizyne.com
- net income and valuation multiples indicators:
IZTC - Net Income|Projected Future Earnings Invizyne Technologies Inc.|IZTC - Company Value to Net Income|Future Price to Earnings Invizyne|IZTC - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Invizyne Corp|IZTC - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Invizyne Technologies|IZTC - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months invizyne.com|IZTC - Earnings per share growth rate in current year|Earnings growth forecast for next year Invizyne Technologies Inc.
- revenue and sales details:
Summary company analysis:Invizyne Technologies (IZTC)
The forward P/S ratio compares the current market capitalization of Invizyne Technologies Inc. (IZTC) with expected revenue and gross profit volumes, filtering out price volatility. By analyzing the projected P/S valuation, an investor can track the confidence trend in a startup whose achievements in cell-free synthesis and the implementation of sustainable chemical synthesis determine the business's scaling potential and the justification of current valuation multiples.
Competing companies
Forward P/S Multiple LIN (Linde)|Market Cap to Expected Sales Ratio Air Products & Chemicals, Inc. (APD)|DD: Forward Price-to-Revenue Multiple|Future Price to Revenue IP|PPG (ppg.com) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio dow.com (DOW)|Price-to-Projected Revenue Ratio LyondellBasell|Market Cap to Projected Revenue IFF (IFF Inc.)|Forward P/S Multiple RPM|ENTG - Market Cap to Future Revenue Ratio|Suzano S.A. - Forward Price-to-Revenue Multiple|Forward Price to Sales WLK|ALB: Forward Price-to-Revenue Multiple|Israel Chemicals - Price to Expected Revenue Ratio|NEU: Forward P/S Multiple|Market Cap to Future Revenue Ratio Eastman Kodak Chemical (EMN)|AXTA (Axalta Coating Systems) - Forward P/S Multiple|Forward Price-to-Revenue Multiple elementsolutionsinc.com (ESI)|Forward P/S Multiple SQM|CE (Celanese Corp) - Forward Price to Sales|Price-to-Projected Revenue Ratio Sensient Corp SXT|CBT: Market Cap to Projected Revenue|HWKN - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio avient.com|H.B. Fuller (FUL) - Price-to-Projected Revenue Ratio|MEOH (Methanex Corp) - Price-to-Projected Revenue Ratio|Price-to-Projected Revenue Ratio WD-40 Corp|Market Cap to Future Revenue Ratio Chemours Co. CC|Forward P/S Multiple KWR|purecycletech.com (PCT) - Projected Price to Revenue|Forward P/S Multiple ASH (Ashland)|Market Cap to Expected Sales Ratio Ingevity Corp (NGVT)|Innospec Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Minerals Technologies Corp|Daqo New Energy Corp. (DQ) - Price-to-Projected Revenue Ratio|SLVM - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple HUN|AIN: Forward Price to Sales|Forward P/S Multiple CLMT|Market Cap to Expected Sales Ratio Rogers Materials|Price-to-Projected Revenue Ratio Stepan Company SCL|ECVT: Market Cap to Projected Revenue|NeoGenomics - Forward P/S Multiple|REX American Resources Corp (REX) - Forward Price-to-Revenue Multiple|ASPI (ASP Isotopes Corp) - Forward Price-to-Revenue Multiple|TROX - Market Cap to Expected Sales Ratio|GSM (Ferroglobe PLC) - Forward P/S Multiple|wlkpartners.com (WLKP) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CMP (Compass Minerals International)|KRO: Future Price to Revenue|Mativ Corp - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio LXU (LSB Chemical)|Braskem S.A. - Forward P/S Multiple|koppers.com (KOP) - Forward Price-to-Revenue Multiple|ASIX: Forward P/S Multiple|Forward Price-to-Revenue Multiple Orion Engineered Carbons|RYAM (Rayonier Advanced Materials Inc) - Forward P/S Multiple|ADUR: Forward Price to Sales|Forward P/S Multiple MAGN|CLW - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Tredegar TG|CMT - Forward Price-to-Revenue Multiple|FutureFuel Corporation - Forward P/S Multiple|Market Cap to Expected Sales Ratio Flexible Solutions FSI|altoingredients.com (ALTO) - Price-to-Projected Revenue Ratio|FEAM - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple TSE|ORGN (Origin Materials Corp) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Northern Technologies International Corp. (NTIC)|LNZA (LanzaTech Corp) - Forward Price to Sales|J-Star Holding - Forward Price-to-Revenue Multiple|New Era Energy & Digital Inc (NUAI) - Market Cap to Future Revenue Ratio|Bolt Projects - Forward P/S Multiple|Market Cap to Expected Sales Ratio BioNexus Gene Lab Corp. BGLC|Gulf Resources, Inc (GURE) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue CNEY|Forward Price-to-Revenue Multiple ALTM|Price-to-Projected Revenue Ratio DNMR|Forward P/S Multiple GLT|Market Cap to Expected Sales Ratio graphexgroup.com|U.S. Silica Holdings Inc. - Forward Price-to-Revenue Multiple
